Posted in | News | Solar Energy

Solar Power Signs Agreement with CECEP HK to Acquire 4.3MW of Photovoltaic Projects in Italy

Solar Power, Inc. ("SPI"), a vertically-integrated photovoltaic ("PV") developer, today announced that SPI, together with its wholly owned subsidiary, SPI China (HK) Limited, has entered into a stock purchase agreement with CECEP Solar Energy Hong Kong Co., Limited ("CECEP HK"), a wholly owned subsidiary of China Energy Conservation and Environmental Protection Group ("CECEP"), a top state-owned energy conglomerate in China, to acquire 4.3 megawatts ("MW") of photovoltaic projects in Italy.

Under the terms of the stock purchase agreement, SPI HK will acquire all of the outstanding capital stock of the holding companies wholly owned by CECEP HK that hold the Italian projects for an aggregate consideration of EUR 12,500,000, in the form of EUR 9,375,000 of SPI's shares of common stock and EUR 3,125,000 of cash.

Xiaofeng Peng, Chairman of SPI, stated, "We are delighted to announce this agreement with CECEP HK, which also marks the start of a significant strategic alliance with CECEP, a top Chinese state-owned energy conglomerate. Upon closing, this acquisition will bring significant European operating assets into SPI's globally diversified PV portfolio. SPI will continue to pursue additional strategic partnerships to drive growth for the benefit of our shareholders and partners."

About Solar Power, Inc. (OTCBB: SOPW)

Solar Power, Inc. ("SPI") is a vertically-integrated photovoltaic developer offering its own brand of high-quality, low-cost distributed generation and utility-scale solar energy facility development services. From project development, to project financing and to post-construction asset management, SPI delivers turnkey world-class photovoltaic solar energy facilities and turnkey residential solar solutions to its business, government and utility customers. For additional information visit: www.spisolar.com.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.